Israel Chemicals (NYSE:ICL) Upgraded at Zacks Investment Research

Share on StockTwits

Zacks Investment Research upgraded shares of Israel Chemicals (NYSE:ICL) from a sell rating to a hold rating in a research report released on Thursday morning, Zacks.com reports.

According to Zacks, “Israel Chemicals Ltd. is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions. It operates primarily in three markets: agriculture, food and engineered materials. The Company’s products include bromine specialty chemicals, potash, phosphate fertilizers, and specialty performance and industrial products. It markets its products primarily in Israel, Europe, and the Americas. Israel Chemicals Ltd. is headquartered in Tel Aviv, Israel. “

Separately, Barclays began coverage on shares of Israel Chemicals in a report on Thursday, January 16th. They issued an equal weight rating on the stock. Three research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus target price of $6.00.

Shares of ICL opened at $3.83 on Thursday. The firm has a market capitalization of $4.90 billion, a PE ratio of 10.35, a price-to-earnings-growth ratio of 0.98 and a beta of 0.95. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.52 and a quick ratio of 0.78. Israel Chemicals has a 1-year low of $3.79 and a 1-year high of $5.73. The company’s fifty day moving average price is $4.32 and its 200-day moving average price is $4.61.

Israel Chemicals (NYSE:ICL) last posted its quarterly earnings results on Thursday, February 13th. The basic materials company reported $0.04 EPS for the quarter, meeting the consensus estimate of $0.04. Israel Chemicals had a net margin of 9.01% and a return on equity of 11.82%. The company had revenue of $1.11 billion for the quarter. As a group, research analysts anticipate that Israel Chemicals will post 0.41 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 18th. Shareholders of record on Wednesday, March 4th will be issued a $0.018 dividend. This represents a $0.07 annualized dividend and a yield of 1.88%. The ex-dividend date of this dividend is Tuesday, March 3rd.

Large investors have recently bought and sold shares of the business. Lindbrook Capital LLC boosted its holdings in Israel Chemicals by 149.6% in the third quarter. Lindbrook Capital LLC now owns 5,472 shares of the basic materials company’s stock valued at $27,000 after purchasing an additional 3,280 shares during the last quarter. Parallel Advisors LLC boosted its holdings in Israel Chemicals by 126.1% in the third quarter. Parallel Advisors LLC now owns 7,364 shares of the basic materials company’s stock valued at $37,000 after purchasing an additional 4,107 shares during the last quarter. Marshall Wace LLP purchased a new stake in Israel Chemicals in the fourth quarter valued at $36,000. First Trust Advisors LP purchased a new stake in Israel Chemicals in the first quarter valued at $73,000. Finally, CWM Advisors LLC purchased a new stake in Israel Chemicals in the fourth quarter valued at $70,000. 6.21% of the stock is currently owned by institutional investors.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.

See Also: Inverted Yield Curve

Get a free copy of the Zacks research report on Israel Chemicals (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.